stockrowAtara Biotherapeutics, Inc. (ATRA) vs Equillium, Inc. (EQ)
- Atara Biotherapeutics, Inc. ATRA 7.94 −0.25%
- Equillium, Inc. EQ 1.51 +13.53%
Atara Biotherapeutics, Inc. and Equillium, Inc. are both Biotechnology companies. Atara Biotherapeutics, Inc. and Equillium, Inc. are of similar size ($84.3M and $79.9M). Equillium, Inc. grew revenue faster over the last twelve months: 13.9% against −96.7%. Equillium, Inc. has the higher net margin (0.00% vs −269.4%) and the higher return on invested capital (0.00% vs 0.00%). Across the 14 metrics below, Equillium, Inc. leads on 11 and Atara Biotherapeutics, Inc. on 3.
Valuation
Profitability
| Metric | ATRA | EQ | Biotechnology median |
|---|---|---|---|
| Gross margin | 91.38% | 100.00% | 68.51% |
| Operating margin | (229.67%) | 0.00% | 0.00% |
| Net margin | (269.42%) | 0.00% | 0.00% |
| Free cash flow margin | (353.49%) | 0.00% | 0.00% |
| Return on equity | 46.33% | (58.98%) | (51.96%) |
| Return on assets | (57.62%) | (50.68%) | (46.06%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack